Results

Total Results: 1,151 records

Showing results for "drugs".

181. Murray MD et al. 1998 "Effects of computer-based prescribing on pharmacist work patterns." | Digital Healthcare Research
     digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/murray-md-et-al-1998
     January 01, 1998 - order by typing in a few letters of the medication's name or can peruse a specific formulary class of drugs

182. Service Integration - 2008 | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/service-integration/annual-summary/2008
     January 01, 2008 - purpose of the proposed project is to expand ByNet’s existing efforts to increase access to prescription drugs

183. Using Precision Performance Measurement to Conduct Focused Quality Improvement - 2011 | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/using-precision-performance-measurement-conduct-focused-quality-improvement/annual-summary/2011
     January 01, 2011 - Performance did not change during Phase 2 for prescribing antiplatelet drugs for patients with coronary

184. Preventing Wrong-Drug and Wrong-Patient Errors With Indication Alerts in CPOE Systems | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/preventing-wrong-drug-and-wrong-patient-errors-indication-alerts-cpoe-systems
     January 01, 2023 - Preventing Wrong-Drug and Wrong-Patient Errors With Indication Alerts in CPOE Systems Project Final Report ( PDF , 953.21 KB) Disclaimer Disclaimer The findings and conclusions in this document are those of the author(s), who are responsible for its content, and do not necessaril…

185. Ferranti, Jeffrey | Digital Healthcare Research
     digital.ahrq.gov/principal-investigator/ferranti-jeffrey
     January 01, 2023 - Ferranti, Jeffrey Sharing adverse drug event data using business intelligence technology. Citation Horvath MM, Cozart H, Ahmad A, et al. Sharing adverse drug event data using business intelligence technology. J Patient Saf 2009 Mar;5(1):35-41. Principal Investigator …

186. Structured product labeling improves detection of drug-intolerance issues. | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/value-new-drug-labeling-knowledge-e-prescribing/citation/structured-product
     January 01, 2023 - Structured product labeling improves detection of drug-intolerance issues. Citation Schadow G. Structured product labeling improves detection of drug-intolerance issues. AMIA Annu Symp Proc 2008 Nov 6:646. Link Schadow G. Structured product labeling improves detection of drug-intolerance i… …

187. Structured product labeling improves detection of drug-intolerance issues. | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/value-new-drug-labeling-knowledge-e-prescribing/citation/structured-product-0
     January 01, 2023 - Structured product labeling improves detection of drug-intolerance issues. Citation Schadow G. Structured product labeling improves detection of drug-intolerance issues. J Am Med Inform Assoc 2009 Mar-Apr;16(2):211-9. Link Schadow G. Structured product labeling improves detection of drug-intol…

188. The Discharge Assistant: Facilitating Information Transfer at Hospital Discharge (pdf file)
     digital.ahrq.gov/sites/default/files/docs/page/2006Nace_051811comp.pdf
     January 01, 2001 - the discharging physician ● 73% of patients fail to use at least one medicine as directed ● 32% of drugs

189. Tailoring adverse drug event surveillance to the paediatric inpatient. | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/automated-adverse-drug-event-detection-and-intervention/citation/tailoring
     January 01, 2023 - Tailoring adverse drug event surveillance to the paediatric inpatient. Citation Long AL, Horvath MM, Cozart H, et al. Tailoring adverse drug event surveillance to the paediatric inpatient. Qual Saf Health Care 2010 Oct;19(5):e40. Link Long AL, Horvath MM, Cozart H, et al. Tailoring adverse dru…

190. Bailey, Thomas | Digital Healthcare Research
     digital.ahrq.gov/principal-investigator/bailey-thomas
     January 01, 2023 - Bailey, Thomas Natural language processing to identify adverse drug events. Citation Gysbers M, Reichley R, Kilbridge PM, et al. Natural language processing to identify adverse drug events. AMIA Annu Symp Proc 2008 Nov 6:961. Principal Investigator Bailey, Thomas …

191. Colchicine drug interaction errors and misunderstandings: Recommendations for improved evidence-based management. | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/meaningful-drug-interaction-alerts/citation/colchicine
     January 01, 2023 - Colchicine drug interaction errors and misunderstandings: Recommendations for improved evidence-based management. Citation Hansten PD, Tan MS, Horn JR, Gomez-Lumbreras A, Villa-Zapata L, Boyce RD, Subbian V, Romero A, Gephart S, Malone DC. Colchicine drug interaction errors and misunderstandings: Reco…

192. Automated Adverse Drug Event Detection and Intervention - Final Report | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/automated-adverse-drug-event-detection-and-intervention/final-report
     January 01, 2023 - Automated Adverse Drug Event Detection and Intervention - Final Report Citation Ferranti J. Automated Adverse Drug Event Detection and Intervention - Final Report. (Prepared by Duke University under Grant No. UC1 HS014882). Rockville, MD: Agency for Healthcare Research and Quality; 2008. PDF …

193. Value of New Drug Labeling Knowledge for e-Prescribing - Final Report | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/value-new-drug-labeling-knowledge-e-prescribing/final-report
     January 01, 2023 - Value of New Drug Labeling Knowledge for e-Prescribing - Final Report Citation Schadow G. Value of New Drug Labeling Knowledge for e-Prescribing - Final Report. (Prepared by Indiana University-Purdue University at Indianapolis under Grant No. R01 HS015377). Rockville, MD: Agency for Healthcare Resear…

194. Virtual Patient Advocate to Reduce Ambulatory Adverse Drug Events - Final Report | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/virtual-patient-advocate-reduce-ambulatory-adverse-drug-events/final-report
     January 01, 2023 - Virtual Patient Advocate to Reduce Ambulatory Adverse Drug Events - Final Report Citation Jack B. Virtual Patient Advocate to Reduce Ambulatory Adverse Drug Events - Final Report. (Prepared by Boston Medical Center under Grant No. R18 HS017196). Rockville, MD: Agency for Healthcare Research and Qualit…

195. CDS Standards and Regulatory Frameworks Workgroup: An Initial Taxonomy of Override Reasons for PC CDS Recommendations (pdf file)
     digital.ahrq.gov/sites/default/files/SRF_Taxonomy%20of%20PC%20CDS%20Override%20Recommendations_508_0.pdf
     July 01, 2024 - /patient 5 allergies,5 8 12 16 26 27 28 29 30 31 32 formulary substitutions,8 27 duplicate drugs … anticoagulation for atrial fibrillation may decide that they cannot take one of the novel anticoagulant drugs

196. Surveillance for Adverse Drug Events in Ambulatory Pediatrics - Final Report | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/surveillance-adverse-drug-events-ambulatory-pediatrics/final-report
     January 01, 2023 - Surveillance for Adverse Drug Events in Ambulatory Pediatrics - Final Report Citation Bailey TC, Kilbridge PM. Surveillance for Adverse Drug Events in Ambulatory Pediatrics – Final Report. (Prepared by Washington University School of Medicine under Grant No. R18 HS017010). Rockville, MD: Agency for He…

197. Individualized Drug Interaction Alerts - Final Report | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/individualized-drug-interaction-alerts/final-report
     January 01, 2023 - Individualized Drug Interaction Alerts - Final Report Citation Malone D. Individualized Drug Interaction Alerts - Final Report. (Prepared by the University of Arizona under Grant No. R21 HS023826). Rockville, MD: Agency for Healthcare Research and Quality, 2017. PDF Individualized Drug I…

198. A prescription for improving drug formulary decision making. | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics-11
     January 01, 2023 - A prescription for improving drug formulary decision making. Citation Schiff GD, Galanter WL, Duhig J, et al. A prescription for improving drug formulary decision making. PLoS Med 2012;9(5):1-7. Link Schiff GD, Galanter WL, Duhig J, et al. A prescription for improving drug formu… Princip…

199. The costs of adverse drug events in community hospitals. | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics-1
     January 01, 2023 - The costs of adverse drug events in community hospitals. Citation Hug BL, Keohane C, Seger DL, et al. The costs of adverse drug events in community hospitals. Jt Comm J Qual Patient Saf 2012 Mar;38(3):120-6. Link Hug BL, Keohane C, Seger DL, et al. The costs of adverse drug events in communi… …

200. Meaningful Drug Interaction Alerts - Final Report | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/meaningful-drug-interaction-alerts/final-report
     January 01, 2023 - Meaningful Drug Interaction Alerts - Final Report Citation Malone D. Meaningful Drug Interaction Alerts - Final Report. (Prepared by University of Utah under Grant No. R01 HS025984). Rockville, MD: Agency for Healthcare Research and Quality, 2023. PDF final report The findings a…